#United States #CS Analytical #Clifton, NJ #Brandon Zurawlow #Sandra Cincotta

CS Analytical Laboratory Elevates Leadership Team

CS Analytical Laboratory, renowned for being the sole FDA regulated contract lab dedicated to regulatory solutions and qualification testing services for drug products and medical device container systems, recently announced two significant executive promotions as part of its strategy to enhance leadership amid substantial operational growth.

Strategic Promotions in Leadership

On January 28, 2025, the laboratory appointed Brandon Zurawlow as Chief Operations Officer and Sandra Cincotta as Vice-President of Quality. These roles come at a time when the company is undergoing remarkable growth, necessitating a development in its leadership team. As stated by Brian Mulhall, the Chief Executive Officer, these appointments are essential for maintaining a clear vision and effective oversight as CS Analytical continues on its path of expansion and innovation.

Brandon Zurawlow, who has over 14 years of expertise in container and package system qualification testing, has been a cornerstone in formulating processes that meet and surpass client expectations. His profound knowledge in USP 1207 Container Closure Integrity Testing (CCIT) positions him among the world’s foremost experts in the field. In his new role as Chief Operations Officer, Brandon is set to extend his influence into all operational aspects to innovate systems that align with market requirements.

Sandra Cincotta, on the other hand, brings over 25 years of quality system leadership experience to her new position as Vice-President of Quality. She has played a vital role in constructing an entirely electronic quality system for CS Analytical, which has notably enhanced laboratory efficiency while saving time and costs for clients. Sandra's experience with regulatory bodies, coupled with her track record of successfully navigating numerous FDA inspections without any citations, fortifies her reputation as a leading figure in quality management. In her elevated role, she aims to implement further quality processes that keep CS Analytical at the forefront of the industry.

A Unique Market Position

CS Analytical stands out as the only FDA regulated, cGMP laboratory that focuses exclusively on drug and medical device container and package qualification testing. The company's team comprises leading experts proficient in all relevant USP and EP requirements. They are also pioneers in Container Closure Integrity (CCI) testing, offering a comprehensive suite of laboratory services including USP, EP, and JP procedures tailored specifically for various materials like glass, plastic, and elastomers.

Moreover, CS Analytical provides essential services such as feasibility studies, component qualification programs, and advanced method development for helium leak testing, vacuum decay, and additional techniques. Their commitment to meeting rigorous regulatory requirements solidifies their reputation as a singular resource within this specialized field.

Future Outlook

With Brandon and Sandra at the helm, CS Analytical Laboratory is poised for significant advancements in its operational capabilities and service offerings. Their leadership will not only enhance quality management but will also ensure the continual development of innovative solutions tailored to meet the complex needs of regulatory compliance in the pharmaceutical and medical device sectors.

As the company aims for ongoing growth and the expansion of its market reach, it remains dedicated to providing unparalleled services that adhere to the highest standards of regulatory requirements, ensuring that clients can trust in the integrity of their container and packaging solutions.